One in two adults have gum disease
Continue reading on Colgate's website.
On Wednesday (11) it was reported in the Journal of Allergy and Clinical Immunology, a study by researchers at the University of Michigan, USA, who developed a vaccine that could end peanut allergy. The experiment was performed with mice, which received three monthly doses of a nasal vaccine to protect them from allergic reactions after peanut exposure.
According to the International Aids Society this is an exciting breakthrough. Human trials will begin in 2018 to see if it is possible to prevent or treat infections. According to Linda-Gail Bekker, the group's president, these antibodies seem to go beyond the natural and may have applications than anticipated.
- Laziness or Procrastination: Why do we have the habit of postponing things?
- Overprotective parents increase child's chances of bullying
- Thermotherapy: know the pros and cons of the treatment for cellulite
- Federal Court bans sale of medicine for childhood leukemia
- Fear of height: see how to identify this phobia and treatments